A Rollover Study of Alectinib in Patients With Anaplastic Lymphoma Kinase (ALK)-Positive or Rearranged During Transfection (RET)-Positive Cancer
Hoffmann-La Roche
Hoffmann-La Roche
Rezolute
Novartis
Novartis
Philipps University Marburg
Novartis
INSYS Therapeutics Inc